steroid

Tirzepatide has emerged as a breakthrough treatment option for individuals dealing with type 2 diabetes and obesity. Its unique mechanism of action, being a dual agonist for the GIP (Gastric Inhibitory Polypeptide) and GLP-1 (Glucagon-Like Peptide-1) receptors, allows it to address both glucose regulation and appetite control effectively. As this medication gains popularity, understanding its...